Metropolitan Life Insurance CO Sangamo Therapeutics, Inc Transaction History

Metropolitan Life Insurance CO

$2.27 Billion
Q1 2024

51 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.66 - $3.67 $1,137 - $2,513	-685 Reduced 8.55%	7,330 $12,000
Q4 2022 Jun 14, 2023	BUY	$2.77 - $5.07 $1,897 - $3,472	685 Added 9.35%	8,015 $25.2 Million
Q4 2022 Mar 30, 2023	BUY	$2.77 - $5.07 $5,340 - $9,774	1,928 Added 31.67%	8,015 $25,000
Q4 2022 Feb 15, 2023	BUY	$2.77 - $5.07 $5,340 - $9,774	1,928 Added 31.67%	8,015 $25,000
Q3 2022 Jun 14, 2023	SELL	$4.27 - $6.39 $5,307 - $7,942	-1,243 Reduced 16.96%	6,087 $29.8 Million

Q3 2022 Mar 30, 2023	SELL	$4.27 - $6.39 $8,463 - $12,664	-1,982 Reduced 24.56%	6,087 $29,000
Q3 2022 Nov 14, 2022	SELL	$4.27 - $6.39 $8,463 - $12,664	-1,982 Reduced 24.56%	6,087 $30,000
Q2 2022 Jun 20, 2023	BUY	$3.28 - $6.21 $2,423 - $4,589	739 Added 10.08%	8,069 $33,000
Q1 2022 Jun 20, 2023	BUY	$5.23 - $7.82 $3,864 - $5,778	739 Added 10.08%	8,069 $46,000
Q1 2022 Mar 30, 2023	SELL	$5.23 - $7.82 $115,640 - $172,908	-22,111 Reduced 73.26%	8,069 $46,000
Q1 2022 May 12, 2022	SELL	$5.23 - $7.82 $115,640 - $172,908	-22,111 Reduced 73.26%	8,069 $47,000
Q4 2021 Jun 21, 2023	BUY	$7.29 - $10.97 $166,576 - $250,664	22,850 Added 311.73%	30,180 $226,000
Q4 2021 Mar 30, 2023	SELL	$7.29 - $10.97 $41,319 - $62,177	-5,668 Reduced 15.81%	30,180 $226,000
Q4 2021 Feb 15, 2022	SELL	$7.29 - $10.97 $41,319 - $62,177	-5,668 Reduced 15.81%	30,180 $226,000
Q3 2021 Jun 21, 2023	BUY	$9.01 - $12.01 $256,947 - $342,501	28,518 Added 389.06%	35,848 $322,000
Q2 2021 Jun 21, 2023	BUY	$10.17 - $12.64 $290,028 - $360,467	28,518 Added 389.06%	35,848 $429,000
Q2 2021 Mar 30, 2023	BUY	$10.17 - $12.64 $30,703 - $38,160	3,019 Added 9.2%	35,848 $429,000
Q2 2021 Aug 16, 2021	BUY	$10.17 - $12.64 $364,238 - $452,701	35,815 Added 108530.3%	35,848 $429,000
Q1 2021 Jun 26, 2023	BUY	$10.88 - $17.05 $277,429 - $434,757	25,499 Added 347.87%	32,829 $411 Million
Q1 2021 Mar 30, 2023	SELL	$10.88 - $17.05 $23,740 - $37,203	-2,182 Reduced 6.23%	32,829 $411,000
Q1 2021 May 14, 2021	SELL	$10.88 - $17.05 $380,560 - $596,374	-34,978 Reduced 99.91%	33 $411,000
Q4 2020 Jun 22, 2023	BUY	$9.23 - $18.18 $255,495 - $503,240	27,681 Added 377.64%	35,011 $546,000
Q3 2020 Jun 26, 2023	BUY	$9.38 - $12.48 $259,647 - $345,458	27,681 Added 377.64%	35,011 $330,000
Q3 2020 Mar 30, 2023	SELL	$9.38 - $12.48 $4,783 - $6,364	-510 Reduced 1.44%	35,011 $330,000
Q3 2020 Nov 13, 2020	SELL	$9.38 - $12.48 $4,783 - $6,364	-510 Reduced 1.44%	35,011 $331,000
Q2 2020 Jun 26, 2023	BUY	$6.21 - $11.83 $175,066 - $333,499	28,191 Added 384.6%	35,521 $318,000
Q2 2020 Mar 30, 2023	BUY	$6.21 - $11.83 $21,039 - $40,080	3,388 Added 10.54%	35,521 $318,000
Q2 2020 Aug 14, 2020	BUY	$6.21 - $11.83 $21,039 - $40,080	3,388 Added 10.54%	35,521 $318,000
Q1 2020 Jul 12, 2023	BUY	$5.05 - $8.85 $125,255 - $219,506	24,803 Added 338.38%	32,133 $204,000
Q1 2020 Mar 30, 2023	SELL	$5.05 - $8.85 $22,760 - $39,886	-4,507 Reduced 12.3%	32,133 $204,000
Q1 2020 May 15, 2020	SELL	$5.05 - $8.85 $22,760 - $39,886	-4,507 Reduced 12.3%	32,133 $205,000
Q4 2019 Jul 12, 2023	BUY	$8.03 - $11.7 $235,359 - $342,927	29,310 Added 399.86%	36,640 $306,000
Q4 2019 Mar 30, 2023	SELL	$8.03 - $11.7 $13,265 - $19,328	-1,652 Reduced 4.31%	36,640 $306,000
Q4 2019 Feb 14, 2020	SELL	$8.03 - $11.7 $13,265 - $19,328	-1,652 Reduced 4.31%	36,640 $307,000
Q3 2019 Jul 12, 2023	BUY	$9.05 - $12.22 $280,206 - $378,355	30,962 Added 422.4%	38,292 $346,000
Q3 2019 Mar 30, 2023	BUY	$9.05 - $12.22 $59,340 - $80,126	6,557 Added 20.66%	38,292 $346,000
Q3 2019 Nov 14, 2019	BUY	$9.05 - $12.22 $59,340 - $80,126	6,557 Added 20.66%	38,292 $347,000
Q2 2019 Jul 12, 2023	BUY	$8.75 - $13.03 $236,512 - $352,200	27,030 Added 368.76%	34,360 $370,000
Q1 2019 Jul 13, 2023	BUY	$7.72 - $12.81 $188,406 - $312,628	24,405 Added 332.95%	31,735 $302,000
Q1 2019 Mar 30, 2023	BUY	$7.72 - $12.81 $183,118 - $303,853	23,720 Added 295.95%	31,735 $302,000
Q1 2019 May 16, 2019	SELL	$7.72 - $12.81 $332,925 - $552,431	-43,125 Reduced 57.61%	31,735 $302,000
Q1 2019 May 15, 2019	BUY	$7.72 - $12.81 $320,827 - $532,357	41,558 Added 124.79%	74,860 $949,000
Q4 2018 Jul 13, 2023	BUY	$9.51 - $16.6 $246,993 - $431,135	25,972 Added 354.32%	33,302 $382,000
Q4 2018 Feb 14, 2019	BUY	$9.51 - $16.6 $247,345 - $431,749	26,009 Added 356.63%	33,302 $382,000
Q3 2018 Jul 13, 2023	BUY	$13.05 - $19.05 $338,934 - $494,766	25,972 Added 354.32%	33,302 $564 Million
Q3 2018 Nov 14, 2018	SELL	$13.05 - $19.05 $339,417 - $495,471	-26,009 Reduced 78.1%	7,293 $124,000
Q2 2018 Aug 15, 2018	BUY	$13.9 - $19.8 $84,234 - $119,988	6,060 Added 22.25%	33,302 $0
Q1 2018 May 15, 2018	BUY	$16.7 - $26.35 $17,351 - $27,377	1,039 Added 3.97%	27,242 $0
Q4 2017 Feb 15, 2018	SELL	$11.6 - $17.35 $346,700 - $518,556	-29,888 Reduced 53.28%	26,203 $430,000
Q3 2017 Nov 14, 2017	BUY	$8.4 - $15.0 $65,175 - $116,385	7,759 Added 16.05%	56,091 $841,000
Q2 2017 Aug 14, 2017	BUY	N/A	48,332	48,332 $425,000

Others Institutions Holding SGMO

# of Institutions

138

Shares Held

100M

Call Options Held

35.5K

Put Options Held

65.8K

Wasatch Advisors Inc Salt Lake City, UT

20.1M
Shares

$7.25 Million
0.07% of portfolio
Armistice Capital, LLC New York, NY

17M
Shares

$6.11 Million
0.15% of portfolio
Black Rock Inc. New York, NY

13.3M
Shares

$4.78 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

12.2M
Shares

$4.39 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

4.94M
Shares

$1.78 Million
0.01% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $56.4M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account